Vigorous- Versus Moderate-intensity Exercise to Reduce Liver Fat in Adults With Obesity and NAFLD
NCT06124456 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330
Last updated 2024-07-09
Summary
Non-alcoholic fatty liver disease (NAFLD) arising from obesity has become a global health concern. Although exercise is a cornerstone approach for managing NAFLD, detailed exercise prescription guidelines are unavailable. According to World Health Organization (WHO) recommendations, 1 minute of vigorous-intensity physical activity can achieve equivalent health benefits to 2 minutes of moderate-intensity physical activity. It is not known whether this relationship is applicable to exercise prescribed as an adjunct therapy in NAFLD treatment. The answer has public health implications because people living with NAFLD can potentially opt for safe higher-intensity exercise requiring less of a time commitment, whereas those in older age groups or with comorbidities, for whom vigorous exercise is unsuitable, can adopt a moderate-intensity regimen of longer duration to acquire equivalent therapeutic outcomes. Adults with obesity and NAFLD will be randomly allocated to a supervised vigorous- or moderate-intensity walking group or usual care control group. Each exercise group will receive a 16-week intervention comprising three walking sessions weekly, whereas the usual care group will receive general health education as the attention control. The per-session walking time will be 25 minutes for the vigorous group and 50 minutes for the moderate group, equating to the same weekly exercise volume and caloric expenditure for each group according to the WHO's minimum physical activity recommendation. Outcome measures, including liver fat, visceral and body fat, body anthropometry, intervention adherence, psychological measures, health-related quality of life, medication usage, adverse events, habitual physical activity, and diet, will be examined by assessors blinded to the group allocation at baseline, 16 weeks (post-intervention), and 42 weeks (26-week post-intervention follow-up). Data will be analyzed by generalized estimating equations and linear contrasts. The proposed study will provide evidence on the presumed equivalent benefits of vigorous- and moderate-intensity exercise, with a follow-up period allowing assessment of the efficacy, safety, adherence, and sustainability of each. The findings will inform practitioners of the role of exercise intensity in reducing liver fat and refine the exercise guidelines for NAFLD patients.
Conditions
- Obesity
- NAFLD
Interventions
- OTHER
-
Usual Care Control Group
Subjects in the usual care control group will receive health education as the attention control. The program will consist of eight 150-minute bi-weekly sessions covering major health issues relating to general health and NAFLD, to be obtained from publicly accessible resources from the Hong Kong Department of Health. Health education information on non-communicable diseases (e.g., cancers, diabetes, coronary heart diseases, obesity, and mental illness), infectious diseases (e.g., COVID-19), and a healthy lifestyle (e.g., balanced diet, physical activity, good sleep, tobacco use, alcohol cessation, and stress management) will also be distributed to the subjects in the exercise groups through recorded presentation videos and leaflets/pamphlets during the first 16 weeks.
- OTHER
-
Moderate-intensity Exercise Intervention
The walking time in each session will be 50 minutes for the moderate-intensity group. The overall weekly exercise volume for the two groups will be the same based on total energy expenditure, as per the WHO's physical activity recommendation (150 minutes of moderate-intensity physical activity weekly is equivalent to 75 minutes of vigorous-intensity physical activity weekly). Five minutes of walking at a normal pace will be included for warm-up and cool-down.
- OTHER
-
Vigorous-intensity Exercise Intervention
The walking time in each session will be 25 minutes for the vigorous-intensity group. The overall weekly exercise volume for the two groups will be the same based on total energy expenditure, as per the WHO's physical activity recommendation (150 minutes of moderate-intensity physical activity weekly is equivalent to 75 minutes of vigorous-intensity physical activity weekly). Five minutes of walking at a normal pace will be included for warm-up and cool-down.
Sponsors & Collaborators
-
The University of Hong Kong
lead OTHER
Principal Investigators
-
Parco M Siu, PhD · LKS Faculty of Medicine, The University of Hong Kong
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-23
- Primary Completion
- 2026-10-31
- Completion
- 2027-01-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease
NCT00815009 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese Adults
NCT03972631 ·Status: UNKNOWN ·Phase: NA
-
Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
NCT03848390 ·Status: UNKNOWN ·Phase: NA
-
Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease
NCT04463667 ·Status: UNKNOWN ·Phase: NA
-
Exercise Study in Subjects With NAFLD
NCT03995056 ·Status: COMPLETED ·Phase: NA
-
Alternate Day Fasting, Exercise, and NAFLD
NCT04004403 ·Status: COMPLETED ·Phase: NA
-
Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study
NCT04440540 ·Status: TERMINATED ·Phase: NA
-
Effect of Weight Loss and Exercise on Liver and Muscle Fat in Obese Elderly
NCT00779207 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)
NCT01834300 ·Status: COMPLETED ·Phase: NA
-
Changes in Intrahepatic Lipids With Exercise
NCT02181270 ·Status: COMPLETED ·Phase: NA
-
Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical Activity
NCT02427087 ·Status: COMPLETED ·Phase: NA
-
Hepatic and Cardiac Metabolic Flexibility in Obese With NAFLD.
NCT03583437 ·Status: COMPLETED ·Phase: NA
-
The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults
NCT06717828 ·Status: RECRUITING ·Phase: NA
-
Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease
NCT00868933 ·Status: COMPLETED ·Phase: NA
-
The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD?
NCT05987748 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of High-intensity Interval Training (HIIT) Versus Moderate-intensity Continuous Training (MICT) in Reducing Visceral Fat in Adults With Central Obesity
NCT04545320 ·Status: WITHDRAWN ·Phase: NA
-
CPET-based HIIT for MAFLD
NCT07177963 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease
NCT01327443 ·Status: COMPLETED ·Phase: NA
-
Leptin and Liver Enzymes Responses to Aerobic Training in Hepatitis c Patients
NCT04550273 ·Status: UNKNOWN ·Phase: NA
-
Intermittent Fasting for NAFLD in Adults
NCT04899102 ·Status: RECRUITING ·Phase: NA
-
Weight Loss Effect on Circulating Liver Enzymes
NCT02992639 ·Status: COMPLETED ·Phase: NA
-
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195 ·Status: NOT_YET_RECRUITING
-
Effects of Exercise on VLDL-TG Metabolism
NCT03678727 ·Status: COMPLETED
-
OPTIMIzing muScle Preservation in paTients wIth Cirrhosis
NCT05367596 ·Status: COMPLETED ·Phase: NA
-
Weight Management in Nonalcoholic Steatohepatitis
NCT00266019 ·Status: COMPLETED ·Phase: PHASE2